Phase 3
N=125
Telemental Health and Cognitive Processing Therapy for Rural Combat Veterans With Posttraumatic Stress Disorder
Posttraumatic Stress Disorder
Bottom Line
View on ClinicalTrials.gov: NCT00879255 ↗Enrolled (actual)
125
Serious AEs
0.0%
Results posted
Mar 2015
Primary outcome: Primary: Clinician Administered PTSD Scale, for DSM-IV (CAPS IV) — -15.97; -11.22 units on a scale — p=> .05
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 3
- Interventions
- Cognitive Processing Therapy Group Videoteleconference (Behavioral); Cognitive Processing Therapy Group In-Person (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Male
- Sponsor
- US Department of Veterans Affairs
- Primary completion
- Sep 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Clinician Administered PTSD Scale, for DSM-IV (CAPS IV) |
-15.17; -9.61 | > .05 |
| PRIMARY Clinician Administered PTSD Scale, for DSM-IV (CAPS IV) |
-15.17; -9.61 | > .05 |
| PRIMARY Clinician Administered PTSD Scale, for DSM-IV (CAPS IV) |
-15.17; -9.61 | > .05 |
Summary
The immediate objective of this project was to evaluate the clinical effectiveness of a telemental health modality (video-teleconferencing) for providing an evidence-based group intervention (Cognitive Processing Therapy; CPT) to rural OIF/OEF Reservists, National Guardsmen, and veterans suffering with PTSD.
Eligibility Criteria
Inclusion Criteria
- diagnosis of current combat related PTSD determined by the Clinician Administered PSTD Scale (CAPS-IV)
- participants taking psychoactive medications have to have a stable regimen for at least 45 days prior to study entry
Exclusion Criteria
- active psychotic symptoms/disorder as determined by the SCID for DSM-IV
- active homicidal or suicidal ideation as determined by the structured clinical interview
- any significant cognitive impairment or history of Organic Mental Disorder as determined by the structured clinical interview
- active (current) substance dependence as determined by the SCID (lifetime substance dependence/abuse not excluded)
- unwillingness to refrain from substance abuse during treatment
- female veterans
Data sourced from ClinicalTrials.gov (NCT00879255). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.